GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Markets

Neurocrine Biosciences falls 4.41% in Tuesday's session

Published by Global Banking & Finance Review

Posted on October 14, 2026

1 min read
Add as preferred source on Google
NBIX 135.13 -4.41% last traded price, 13 Oct 2026
Previous close
141.37
Market cap
—

Source: Eulerpool. The figures in this article were checked against this snapshot before publication.

Neurocrine Biosciences shares last traded at 135.13 USD, 4.41% below their previous close of 141.37 USD in the United States health care market on 13 October 2026.

Last traded price135.13 USD
Previous close141.37 USD
Change from the previous close-4.41%

Prices of Neurocrine Biosciences (NBIX), listed in United States, in the currency the stock trades in. The last traded price is the last price the shares changed hands at in the session of 13 October 2026, as reported after the market closed. It is not the exchange's official closing price, and the two can differ. The change compares it with the official close of the previous session, 12 October 2026. We report a stock the day it ends a session 2% or more away from its previous close, where at least 100,000 shares traded in the previous session. Source: Eulerpool. How we compile these reports.

Neurocrine Biosciences — daily NBIX Delayed

Related Articles

More from Markets

Explore more articles in the Markets category